• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY: JNJ )

    147.78 -1.78 (-1.19%)
    Streaming Delayed Price Updated: 10:23 AM EDT, Apr 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,582,091
    Open 148.14
    Bid (Size) 147.78 (4)
    Ask (Size) 147.82 (2)
    Prev. Close 149.56
    Today's Range 146.86 - 148.69
    52wk Range 143.13 - 175.97
    Shares Outstanding 2,628,679,824
    Dividend Yield 3.22%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Johnson & Johnson Stocks Elliott Wave Technical Analysis
    Looking for support as we touched 0.618 Z vs. X. If we find resistance on Medium Level at 150 then we can expected further downside. 
    Via Talk Markets
    The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
    Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco. 
    Via InvestorPlace

    Performance

    YTD
    -7.62%
    -7.62%
    1 Month
    -4.79%
    -4.79%
    3 Month
    -7.52%
    -7.52%
    6 Month
    -2.28%
    -2.28%
    1 Year
    -9.71%
    -9.71%

    More News

    Read More
    These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years
    Via The Motley Fool
    Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
    Via The Motley Fool
    Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red
    Via InvestorPlace
    Unpacking the Latest Options Trading Trends in Johnson & Johnson
    Via Benzinga
    No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
    Via Investor's Business Daily
    Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
    From Johnson & Johnson
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    3 Dividend Stocks to Buy Now for Lifelong Income
    Via InvestorPlace
    5 Crash-Proof Stocks to Buy Immediately
    Via InvestorPlace
    3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
    Via InvestorPlace
    MarketBeat Week in Review – 4/15 - 4/19
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Investing for the Long-Term: 3 Stocks With Proven Track Records
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
    Via InvestorPlace
    Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
    Via Benzinga
    Topics Brexit
    Exposures Brexit
    Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
    Via Benzinga
    Topics Product Recall
    Exposures Legal Product Safety
    FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
    Via Benzinga
    Exposures Product Safety
    Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
    Via Talk Markets
    Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
    Via InvestorPlace
    Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
    Via InvestorPlace
    Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
    Via Benzinga
    Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
    Via Benzinga
    Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
    Via InvestorPlace
    Topics Economy
    Exposures Interest Rates
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.